Skip Navigation LinksHome > October 2002 - Volume 97 - Issue 4 > Ischemic Preconditioning Is Capable of Inducing Mitochondria...
Anesthesiology:
Laboratory Investigations

Ischemic Preconditioning Is Capable of Inducing Mitochondrial Tolerance in the Rat Brain

Zhan, Ren-Zhi M.D.*; Fujihara, Hideyoshi M.D.†; Baba, Hiroshi M.D.‡; Yamakura, Tomohiro M.D.†; Shimoji, Koki M.D.§

Free Access
Article Outline
Collapse Box

Author Information

Collapse Box

Abstract

Background: Preconditioning to ischemia is a phenomenon whereby a brief episode of sublethal ischemia and other nonlethal stressors produce protection against a subsequent detrimental ischemic insult. As mitochondrial dysfunction is related to necrotic and apoptotic neuronal death after cerebral ischemia, the authors examined if ischemic preconditioning is capable of inducing mitochondrial tolerance.
Methods: Forebrain ischemia was induced by bilateral common carotid artery occlusion with simultaneous hypotension for 8 min in Wistar rats (275–300 g). A 3-min ischemic episode performed 48 h before the 8-min ischemia was used for preconditioning. The extents of hippocampal CA1 neuronal damage were evaluated 7 days after reperfusion by neuro-specific nuclear protein immunostaining. Brain mitochondria were isolated 48 h after animals were subjected to the sham operation or the 3-min conditioning ischemia. Loss of cytochrome c from mitochondria after cerebral ischemia in vivo and after exposure of brain mitochondria to calcium in vitro was used as an indication of mitochondrial dysfunction.
Results: Results showed that ischemic preconditioning induced by a 3-min ischemic episode dramatically reduced the loss of hippocampal CA1 neurons resulting from a subsequent 8-min ischemia 7 days after reperfusion, and this protection was associated with a preservation of mitochondrial cytochrome c as examined after early reperfusion. Exposure of isolated brain mitochondria to calcium produced a dose-dependent increase in cytochrome c release either at 30°C or at 37°C. Compared with those animals receiving only sham operation, cytochrome c release caused by 100 μm calcium was significantly reduced in conditioned animals.
Conclusion: Regarding the importance of mitochondrial dysfunction in mediating ischemic neuronal death, the above results indicate that mitochondria may serve as end-effecting organelles to ischemic preconditioning.
ISCHEMIC preconditioning is a phenomenon whereby a brief episode of sublethal ischemia and other nonlethal stressors produce protection against a subsequent detrimental ischemic insult; this phenomenon was first described in the heart 1 and in the brain also. 2 Undoubtedly, an understanding of the mechanisms of ischemic tolerance would not only contribute to the development of new strategies for preventing and treating stroke but also would provide insight into what factors mediate ischemic neuronal damage.
To date, the mechanism by which ischemic tolerance is induced remains unclear. Mitochondrial dysfunction is known to occur after cerebral ischemia, and accumulating evidence indicates that mitochondrial dysfunction plays an important role in mediating ischemic neuronal death via either necrosis or apoptosis. 3,4 The release of cytochrome c from mitochondria after reperfusion has received particular attention for the following reasons. Cytochrome c is a small and water-soluble molecule, implying that cytochrome c is easier to be released from mitochondria than other mitochondrial proteins. Studies have shown that an early and persistent loss of cytochrome c selectively occurred in ischemic-vulnerable neurons after cerebral ischemia. 4–6 In addition, certain changes (e.g., increases in intracellular calcium and alterations in Bcl-2 family protein expression) known to occur during and after cerebral ischemia 7–9 are able to alter cytochrome c release in vitro. 10,11 Finally, loss of cytochrome c can cause either necrosis or apoptosis. 12–14 Although the release of cytochrome c from mitochondria in cultured neurons has been shown to be a reversible event in response to apoptotic stimuli, 15 it is not in the case of cerebral ischemia, possibly because of the coexistence of irreversible protein synthesis inhibition. 4
In the present study, we examined if ischemic preconditioning is able to induce mitochondrial tolerance by using loss of cytochrome c as an indication of mitochondrial dysfunction.
Back to Top | Article Outline

Materials and Methods

This study was approved by the Committee on the Guidelines for Animal Experiments of Niigata University.
Back to Top | Article Outline
Forebrain Ischemia Model
For induction of forebrain ischemia, male Wistar rats weighing 275–300 g (aged 8 or 9 weeks) were fasted but allowed to access water for 8–12 h. After animals were anesthetized with 4% halothane and tracheally intubated, they were mechanically ventilated with 1.5% halothane in 30% O2/balance N2O. Two digital thermistor probes (Multi-thermistor meter D321, Technol Seven, Yokohama, Japan) were placed in the rectum and under the left temporalis muscle to monitor core and pericranial temperatures. The left femoral artery and the right external jugular vein were cannulated for continuous monitoring of blood pressure, blood sampling, and blood withdrawing, respectively. Bilateral common carotid arteries were isolated from the carotid sheathes via a ventral midline incision. Fifteen minutes before occlusion of bilateral common carotid arteries, heparin (50 U) was injected intravenously, and an arterial blood sample (0.3 ml) was then taken for blood gas analysis and plasma glucose assay. Animals were acceptable if blood gas parameters and the levels of plasma glu-cose met the following criteria: Po2, 90–140 mmHg; Pco2, 35–45 mmHg; pH, 7.35–7.45; and glucose, 90–150 mg/dl. After mean artery blood pressure was lowered to 35–40 mmHg by injecting 0.5 mg of phentolamine via the vein catheter followed by withdrawing and injecting blood from the external jugular vein catheter via a heparinized syringe, both common carotid arteries were occluded with small vascular clips (60 g) for 8 min. The withdrawn blood was held at 37.5°C. Thereafter, the clips were removed, and the withdrawn blood was reinfused. Reperfusion in each artery was verified visually. During occlusion, the core temperature was controlled at 37.2 ± 0.2°C, whereas the pericranial temperature was allowed to decrease gradually from 36.8 ± 0.2°C at the beginning of occlusion to 36.0 ± 0.2°C at the end of occlusion. Before discontinuation of anesthesia, the vascular catheters were removed, and the wounds were sutured. The endotracheal catheter was removed after recovery of spontaneous respiration and righting reflex. The animals were then kept in a warm, humidified chamber (32 or 33°C) for another 3 h before being returned to their cages. For preconditioning, animals were subjected to a 3-min bilateral common carotid artery occlusion with simultaneous hypotension 48 h before being subjected to lethal ischemia. 4 Sham animals received the same operation without common carotid artery occlusion.
Back to Top | Article Outline
Tissue Preparation
At 24 h or 7 days after sham operation (n = 4 for each time point), single 3-min ischemia (n = 4 for each time point), 8-min ischemia plus the sham operation (n = 4 for each time point), or 8-min ischemia plus a 3-min conditioning ischemia (with an interval of 48 h, n = 4 for each time point), animals were perfused with 1× phosphate-buffered solution (PBS) containing heparin (4 U/ml), followed by 0.01 m periodate–0.075 m lysine–2% paraformaldehyde (PLP) in 0.0375 m PBS (pH 6.3). The whole brain was taken out from the skull, and the cerebellum and the underlying structures were removed. The remained tissue block containing the hippocampi was separated through the midline and postfixed in the same fixative for 4 h. The tissue pieces were then washed in gradually increasing concentrations of sucrose in 1× PBS (10% for 4 h, 15% and 20% for 12 h each) and thereafter rapidly frozen in 2-methylbutane chilled at −80°C. Consecutive coronal sections located around 3.5 mm posterior to bregma were prepared on a microtome and used for immunofluorescent stainings.
Back to Top | Article Outline
Immunofluorescent Stainings for Neuronal Nuclei-specific Protein and Cytochrome C
Ischemic neuronal damage was evaluated 7 days after reperfusion by neuro-specific nuclear protein (NeuN) immunostaining. Sections were washed four times with 1× PBS for 5 min each; incubated for 20 min in 1× PBS containing 0.2% gelatin, 1.5% bovine serum albumin (BSA), and 0.3% Triton X-100; blocked with 5% goat serum diluted in 1× PBS containing 0.3% Triton X-100 and 1.5% BSA for 120 min; incubated with a mouse NeuN monoclonal antibody (5 μg/ml) diluted in the blocking solution at 4°C over night; and washed six times (5 min each) with 1× PBS. The sections were then incubated with a Cy3-conjugated goat antimouse IgG (5 μg/ml) diluted in the blocking solution at 4°C for 4 h, washed 6 times with 1× PBS, mounted in 50% glycerol in 1× PBS, and visualized under a Nikon fluorescence microscope (Optiphot-2, Nikon, Tokyo, Japan). Both the mouse anti-NeuN monoclonal antibody and the Cy3-conjugated goat antimouse IgG were purchased from Chemicon International (Temecula, CA). After photographed, the number of NeuN-positive cells in the whole CA1 pyramidal cell layer was counted by an experimenter blind to the experimental groups and expressed as the number of cells per mm length of the CA1 pyramidal cell layer (neuronal density).
The sections obtained 24 h after reperfusion were used for cytochrome c immunofluorescence staining. A mouse monoclonal antibody (6H2.B4, Pharmingen, San Diego, CA) was used against the native form of cytochrome c (mitochondrial cytochrome c) in situ. The protocol for cytochrome c immunofluorescence staining was described elsewhere. 4 Fluorescein (FITC)-conjugated rabbit antimouse IgG (Jakson ImmunoResearch Labs, West Grove, PA) was used as secondary antibody. Negative controls included the omission of the primary or the secondary antibody. Sections were examined with laser scanning confocal microscopy (MRC 1024, Bio-Rad Laboratories, Hercules, CA), using a 60× oil-immersion lens.
Back to Top | Article Outline
Mitochondrial Isolation and Incubation
Brain mitochondria were isolated according to the method of Rosenthal et al. 16 At 48 h after the sham operation (n = 8) or the 3-min conditioning ischemia (n = 8), animals were anesthetized with an intraperitoneal injection of sodium pentobarbital (100 mg/kg) and then decapitated. The brains were removed and placed in ice-cold isolation buffer containing 225 mm mannitol, 75 mm sucrose, 5 mm HEPES, 1 mm EGTA, and 1 mg/ml of BSA (pH 7.2, adjusted with KOH). The cerebellum and the underlying structures were removed. The remaining brain tissue from single brain was finely minced and homogenized in a Dounce glass tissue homogenizer in 10 ml of isolation buffer containing 5 mg of bacterial protease Nagarse (via six strikes each with a loose-fitting pestle and then a tight-fitting pestle). Homogenate was brought to 30 ml, divided equally into three tubes, and centrifuged at 2,000 g for 3 min. Pellets were resuspended to 10 ml and centrifuged at 2,000 g for 3 min again. The supernatants were pooled, divided equally into three tubes, and centrifuged at 12,000 g for 8 min. The pellets were resuspended in two tubes to 10 ml each with isolation buffer containing 0.02% digitonin and centrifuged at 12,000 g for 10 min to further isolate mitochondria from synaptosomes. The brown mitochondrial pellets without the synaptosomal layer were then suspended again in 10 ml isolation buffer without EGTA and centrifuged at 12,000 g for 10 min. Finally, the mitochondrial pellets were suspended in 100 μl isolation buffer without EGTA and then combined. Protein concentrations were determined by using the method of Lowry with BSA as a standard.
To see how temperature and different concentrations of calcium affect cytochrome c release from isolated mitochondria, mitochondrial samples (1 mg protein/ml) obtained from three normal animals were incubated in a buffer containing 125 mm KCl, 5 mm HEPES, 3 mm ATP, 4 mm MgCl2, 5 mm succinate, and 5 mm glutamate (pH 7.0, adjusted with KOH) at 30°C for 60 min or at 37°C for 30 min in the absence and presence of calcium. For comparing the amount of cytochrome c release resulting from calcium application, samples obtained from sham-operated and conditioned animals were incubated at 30°C for 60 min with or without 100 μm calcium. After incubation, mitochondria were centrifuged at 12,000 g for 6 min. The supernatants (325 μl for each sample) were mixed throughout with 7.5 μl protease inhibitor cocktail (Sigma, St. Louis, MO) and stored at −80°C.
Back to Top | Article Outline
Western Blot Analysis of Cytochrome C
Protein (20 μl) from each sample was boiled in 40 μl sample buffer at 95°C for 4 min and electrophoresed in individual lanes of 15% SDS-PAGE gels as described previously. 4 Samples obtained from the same brain with or without calcium application (paired samples) were loaded adjacently into the same gel. Proteins were then transferred onto a nitrocellulose membrane (Bio-Rad) at 80 V for 75 min. Blots were probed with a mouse monoclonal antibody (7H8.2C12, Pharmingen, San Diego, CA) against the denatured form of cytochrome c at a dilution of 1:2,500 at 4°C for 60 min. After the primary antibody incuba-tion, the membrane was washed and incubated with a horseradish peroxidase-conjugated goat antimouse IgG (1:4,000, American Qualex, San Clemente, CA) for 45 min at room temperature. The immunoreaction was visualized using Amersham enhanced chemiluminescence kit (Amersham Pharmacia Biotech, Buckinghamshire, UK). Cytochrome c release resulting from calcium exposure was normalized to the paired one without calcium exposure by using the National Institutes of Health image program for Windows (v. 1.62, downloaded from http://www.scionimage.com).
Back to Top | Article Outline
Statistical Analysis
Quantitative data are expressed as mean ± SD and analyzed using one-way analysis of variance (ANOVA) or unpaired Student t test. After one-way ANOVA, we used Tukey post hoc test for multiple comparisons. A P value less than 0.05 is considered statistically different.
Back to Top | Article Outline

Results

Fig. 1
Fig. 1
Image Tools
Table 1
Table 1
Image Tools
As shown in figure 1, ischemic preconditioning provided strong protection against ischemic hippocampal CA1 neuronal damage in the rat forebrain ischemia model. In the section obtained from a sham-operated animal, NeuN immunoreactivity was mainly distributed in nuclei (fig. 1A). Although 3-min ischemia resulted in a loss of few hippocampal CA1 neurons (fig. 1B), an 8-min ischemia caused a nearly complete loss of hippocampal CA1 neurons 7 days after reperfusion (fig. 1C). A 3-min ischemia performed 48 h before the 8-min ischemia dramatically reduced the loss of hippocampal CA1 neurons (fig. 1D). Hippocampal CA1 neuronal density in the above-mentioned groups is shown in table 1.
Fig. 2
Fig. 2
Image Tools
Because loss of mitochondrial cytochrome c began soon after reperfusion and was almost completed 24 h after reperfusion, 4 we examined if ischemic preconditioning can attenuate loss of cytochrome c from mitochondria 24 h after reperfusion by means of confocal laser microscopic image. In the sections prepared from sham-operated animals, CA1 neurons have a bright, punctate cytoplasmic distribution of cytochrome c fluorescence (fig. 2A). Compared with sham-operated animals, mitochondrial cytochrome c was only occasionally changed by the 3-min ischemia (fig. 2B), but it was almost completely depleted by an 8-min ischemia (fig. 2C). With a 3-min ischemia performed 48 h before the 8-min ischemia, mitochondrial cytochrome c was largely preserved (fig. 2D). Regardless of how cytochrome c redistribution can cause neurons to die, the results indicate that mitochondrial dysfunction occurred after reperfusion and was attenuated by ischemic preconditioning.
Fig. 3
Fig. 3
Image Tools
As abnormal intramitochondrial calcium accumulation occurs after cerebral ischemia and is known to be important for mitochondrial dysfunction, 17 we tested whether ischemic preconditioning attenuated mitochondrial dysfunction independent of cytosolic factors by using isolated brain mitochondria. Exposure of isolated brain mitochondria to calcium resulted in a dose-dependent increase in cytochrome c release at 30°C and 37°C (fig. 3A). Similar to loss of cytochrome c from mitochondria in response to apoptotic stimuli, 18 cytochrome c release from isolated mitochondria in response to calcium application was largely temperature-independent. Cytochrome c release induced by 100 μm calcium was significantly less in the mitochondrial samples prepared from conditioned animals (n = 8) compared with those obtained from sham-operated animals (n = 8), as shown in figure 3B–D.
Back to Top | Article Outline

Discussion

The major finding of the present study is that ischemic tolerance induced by sublethal ischemia is associated with mitochondrial protection as documented in vivo and in vitro.
Cerebral ischemic tolerance can be achieved not only by sublethal ischemia 19,20 but also by other stressors, including mild mechanical injury, 2 spreading depression 21,22 and pharmacologic inhibition of energy metabolism. 23 Although several mechanisms have been proposed to explain ischemic tolerance, 24 it is not yet resolved whether a common mechanism underlies preconditioning caused by different stresses.
Mitochondrial dysfunction is thought to be relative of ischemic neuronal death. 3,4 Evidence has emerged that ischemic tolerance in the myocardium and neurons induced by transient ischemia and increased intracellular calcium was associated with a preservation of mitochondrial function. 25–28 As the loss of cytochrome c occurs early and persistently after reperfusion and could lead to caspase activation, formation of free radicals, and disturbances of oxidative phosphorylation resulting in either apoptosis or necrosis, depending on intracellular circumstances (e.g., intracellular ATP levels), 4 the loss of cytochrome c from mitochondria was used as an indication of mitochondrial dysfunction in vivo after cerebral ischemia and in vitro after calcium application. By immunofluorescently examining release of cytochrome c from mitochondria in situ, we demonstrated that ischemic tolerance was associated with an attenuation of cytochrome c loss. Regardless of which pathways participate in ischemic neuronal death caused by loss of cytochrome c, an attenuation of cytochrome c loss from mitochondria by ischemic preconditioning indicates that ischemic preconditioning can induce mitochondrial tolerance. The effect of preconditioning may be first on cytosolic factors, which then lead to mitochondrial tolerance that persists until the time at which mitochondria were isolated for testing. For elucidating if ischemic preconditioning is capable of inducing mitochondrial tolerance without ongoing involvement of cytosolic factors, we further examined if brain mitochondria prepared from conditioned animals are more resistant to calcium-induced cytochrome c release. As the levels of intracellular calcium in ischemic-vulnerable cells within 6–8 min of in vivo ischemia could increase as high as 300 μm, 8 we chose to use 100 μm calcium to stimulate cytochrome c release. Clearly, the conditioning ischemia was able to reduce calcium-induced cytochrome c release from mitochondria. Because the amounts of cytochrome c in most brain cells, including the hippocampal CA1 neurons, were almost unchanged after a 3-min ischemic episode, the reduction of calcium-induced cytochrome c release from isolated mitochondria by conditioning ischemia might not result from cytochrome c already having been released.
The mechanism by which ischemic preconditioning induces mitochondrial tolerance is not clear. Possible mechanisms are multiple. As shown in cardiac cells, ischemic preconditioning may activate mitochondrial ATP-dependent potassium channels. 29 Recent studies have shown that activation of mitochondrial ATP-dependent potassium channels reduces loss of mitochondrial cytochrome c because of oxidative stress and hypoxia in the myocardium. 27,30 Further studies should be taken to examine if there are certain changes in mitochondrial ionic channel function after the conditioning ischemia. Another possibility is the expression and redistribution of Bcl-2 family proteins. Bcl-2 family proteins are important endogenous factors in regulating cytochrome c release from mitochondria, in which antiapoptotic proteins (e.g., Bcl-2, Bcl-XL, and others) inhibit, whereas proapoptotic proteins (e.g., Bax, Bad, and others) enhance, cytochrome c release. There is evidence that ischemic preconditioning is able to induce antiapoptotic protein expression without changes in proapoptotic protein expression;31 and, in addition, there is a redistribution of those proteins after ischemia. 32 Beyond the aforementioned pathways, ischemic preconditioning has been shown to enhance the immunoreactivity of manganese superoxide dismutase, 33,34 which may, in turn, play a role in limiting lethal ischemia-induced loss of cytochrome c. 35
In conclusion, the present study demonstrates that ischemic preconditioning is capable of inducing mitochondrial tolerance, implying that mitochondria are the end-effecting organelles to ischemic preconditioning. Further studies are necessary to elucidate the mechanisms responsible for mitochondrial tolerance and to determine whether similar mitochondrial tolerance also occurs in other preconditioning paradigms.
Back to Top | Article Outline

References

1. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1126–36

2. Takahata Y, Shimoji K: Brain injury improves survival of mice following ischemia. Brain Res 1986; 387: 367–71

3. Fiskum G: Mitochondrial participation in ischemic and traumatic neuronal cell death. J Neurotrauma 2000; 17: 843–55

4. Zhan R-Z, Wu C, Fujihara H, Taga K, Qi S, Naito M, Shimoji K: Both caspase-dependent and caspase-independent pathways may be involved in hippocampal CA1 neuronal death because of loss of cytochrome c from mitochondria in a rat forebrain ischemia model. J Cereb Blood Flow Metab 2001; 21: 529–40

5. Nakatsuka H, Ohta S, Tanaka J, Toku K, Kumon Y, Maeda N, Sakanaka M, Sakaki S: Release of cytochrome c from mitochondria to cytocol in gerbil hippocampal CA1 neurons after transient forebrain ischemia. Brain Res 1999; 849: 216–9

6. Ouang Y-B, Tan Y, Comb M, Liu C-L, Martone ME, Siesjö BK, Hu B-R: Survival- and death-promoting events after transient cerebral ischemia: phosphorylation of Akt, release of cytochrome c, and activation of caspase-like proteases. J Cereb Blood Flow Metab 1999; 19: 1126–35

7. Chen J, Graham SH, Nakayama M, Zhu RL, Jin K, Stetler A, Simon RP: Apoptosis repressor genes Bcl-2 and Bcl-x-long are expressed in the rat brain following global ischemia. J Cereb Blood Flow Metab 1997; 17: 2–10

8. Ericinska M, Silver IA: Loss of neuronal calcium homeostasis in ischemia, Primer on Cerebrovascular Diseases. Edited by Welch KMA, Reis DJ, Caplan LR, Siesjö BK, Weir B. New York, Acadamic, 1997, pp 178–83

9. Krajewski S, Mai JK, Krajewska M, Sikorska M, Mossakowski MJ, Reed JC: Upregulation of Bax protein levels in neurons following cerebral ischemia. J Neurosci 1995; 15: 6364–76

10. Andreyev AY, Fahy B, Fiskum G: Cytochrome c release from mitochondria is independent of the mitochondrial permeability transition. FEBS Lett 1998; 439: 373–6

11. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132–6

12. Deshmukh M, Kuida K, Johnson EM Jr: Caspase inhibition extends the commitment to neuronal death beyond cytochrome c release to the point of mitochondrial depolarization. J Cell Biol 2000; 150: 131–43

13. Mootha VK, Wei MC, Buttle KF, Scorrano L, Panoutsakopoulou V, Mannella CA, Korsmeyer SJ: A reversible component of mitochondrial respiratory dysfunction in apoptosis can be rescued by exogenous cytochrome c. EMBO J 2001; 20: 661–71

14. Waterhouse NJ, Goldstein JC, von Ahsen O, Schuler M, Newmeyer DD, Green DR: Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during apoptotic process. J Cell Biol 2001; 153: 319–28

15. Martinou I, Desagher S, Eskes R, Antonsson B, Andre E, Fakan S, Martinou J-C: The release of cytochrome c from mitochondria during apoptosis of NGF-deprived sympathetic neurons is a reversible event. J Cell Biol 1999; 144: 883–9

16. Rosenthal RE, Hamud F, Fiskum G, Varghese PJ, Sharpe S: Cerebral ischemia and reperfusion: Prevention of brain mitochondrial injury by lidoflazine. J Cereb Blood Flow Metab 1987; 7: 752–8

17. Murphy AN: Ca(2+)-mediated mitochondrial dysfunction and the protective effects of Bcl-2. Ann N Y Acad Sci 1999; 893: 19–32

18. Goldstein JC, Waterhouse NJ, Juin P, Evan GI, Green DR: The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nature Cell Biol 2000; 2: 156–62

19. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Uneda H, Niiobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K, Kamada T: ‘Ischemic tolerance’ phenomenon found in the brain. Brain Res 1990; 528: 21–4

20. Kirino T, Tsujita Y, Tamura A: Induced tolerance to ischemia in gerbil hippocampal neurons. J Cereb Blood Flow Metab 1991; 11: 299–307

21. Kawahara N, Ruetzler CA, Klatzo I: Protective effect of spreading depression against neuronal damage following cardiac arrest cerebral ischaemia. Neurol Res 1995; 17: 9–16

22. Taga K, Patel PM, Drummond JC, Cole DJ, Kelly PJ: Transient neuronal depolarization induces tolerance to subsequent ischemia in rats. A nesthesiology 1997; 87: 918–25

23. Riepe MW, Esclaire F, Kasischke K, Schreiber S, Nakase H, Kempski O, Ludolph AC, Dirnagl U, Hugon J: Increased hypoxic tolerance by chemical inhibition of oxidative phosphorylation: “Chemical preconditioning.” J Cereb Blood Flow Metab 1997; 17: 257–64

24. Nandagopal K, Dawson TM, Dawson VL: Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. J Pharmacol Exp Ther 2001; 297: 474–8

25. Laclau MN, Boudina S, Thambo JB, Tariosse L, Gouverneur G, Bonoron-Adèle S, Saks VA, Garlid KD, Dos Santos P: Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase. J Mol Cell Cardiol 2001; 33: 947–56

26. Dave KR, Saul I, Busto R, Ginsberg MD, Sick TJ, Pérez-Pinzón MA: Ischemic preconditioning preserves mitochondrial function after global cerebral ischemia in rat hippocampus. J Cereb Blood Flow Metab 2001; 21: 1401–10

27. Xu M, Wang Y, Ayub A, Ashraf M: Mitochondrial KATP channel activation reduces anoxic injury by restoring mitochondrial membrane potential. Am J Physiol Heart Circ Physiol 2001; 281: H1295–303

28. Xu M, Wang Y, Hirai K, Ayub A, Ashraf M: Calcium preconditioning inhibits mitochondrial permeability transition and apoptosis. Am J Physiol Heart Circ Physiol 2001; 280: H899–908

29. O'Rourke B: Myocardial KATP channels in preconditioning. Circ Res 2000; 87: 845–55

30. Masahara A, Ohler A, O'Rourke B, Marbán E: Mitochondrial ATP-sensitive potassium channels inhibits apoptosis induced by oxidative stress in cardiac cells. Circ Res 2001; 88: 1267–75

31. Shimazaki K, Ishida A, Kawai N: Increase in Bcl-2 oncoprotein and the tolerance to ischemia-induced neuronal death in the gerbil hippocampus. Neurosci Res 1994; 20: 95–9

32. Gao G, Minami M, Pei W, Yan C, Chen D, O'Horo C, Graham SH, Chen J: Intracellular Bax translocation after transient cerebral ischemia: Implication for a role of the mitochondrial apoptotic signaling pathway in ischemic neuronal death. J Cereb Blood Flow Metab 2001; 21: 321–33

33. Kato H, Kogure K, Araki T, Liu XH, Kato K, Itoyama Y: Immunohistochemical localization of superoxide dismutase in the hippocampus following ischemia in a gerbil model of ischemic tolerance. J Cereb Blood Flow Metab 1995; 15: 60–70

34. Ohtsuki T, Matsumoto M, Kuwabara K, Kitagawa K, Suzuki K, Taniguchi N, Kamada T: Influence of oxidative stress on induced tolerance to ischemia in gerbil hippocampal neurons. Brain Res 1992; 599: 246–52

35. Fujimura M, Morita-Fujimura Y, Kawase M, Copin J-C, Calagui B, Epstein CJ, Chan PH: Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome c and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. J Neurosci 1999; 19: 3414–22

Cited By:

This article has been cited 14 time(s).

Investigative Ophthalmology & Visual Science
Mitochondrial potassium ATP channels and retinal ischemic preconditioning
Roth, S; Dreixler, JC; Shaikh, AR; Lee, KH; Bindokas, V
Investigative Ophthalmology & Visual Science, 47(5): 2114-2124.
10.1167/iovs.05-1068
CrossRef
Neurochemical Journal
Preconditioning modifies the activities of mitogen-activated protein kinases and c-Jun transcription factor in rat hippocampus after severe hypobaric hypoxia
Samoilov, MO; Rybnikova, EA; Sitnik, NA; Glushchenko, TS; Tyulkova, EI; Grinkevich, LN
Neurochemical Journal, 1(3): 219-226.
10.1134/S1819712407030087
CrossRef
Neuroscience
Toll-Like Receptor Signaling in Endogenous Neuroprotection and Stroke
Marsh, BJ; Williams-Karnesky, RL; Stenzel-Poore, MP
Neuroscience, 158(3): 1007-1020.
10.1016/j.neuroscience.2008.07.067
CrossRef
Journal of Cerebral Blood Flow and Metabolism
Depressed responses to applied and synaptically-released GABA in CA1 pyramidal cells, but not in CA1 interneurons, after transient forebrain ischemia
Zhan, RZ; Nadler, JV; Schwartz-Bloom, RD
Journal of Cerebral Blood Flow and Metabolism, 26(1): 112-124.
10.1038/sj.jcbfm.9600171
CrossRef
Acta Pharmacologica Sinica
Isoflurane preconditioning protects against ischemia-reperfusion injury partly by attenuating cytochrome c release from subsarcolemmal mitochondria in isolated rat hearts
Qian, LP; Zhu, SS; Cao, JL; Zeng, YM
Acta Pharmacologica Sinica, 26(7): 813-820.
10.1111/j.1745-7254.2005.00117.x
CrossRef
Cell Calcium
On the role of Ca2+ in cerebral ischemic preconditioning
Tauskela, JS; Morley, P
Cell Calcium, 36(): 313-322.
10.1016/j.ceca.2004.02.008
CrossRef
Journal of Cerebral Blood Flow and Metabolism
Obligatory role of inducible nitric oxide synthase in ischemic preconditioning
Cho, S; Park, EM; Zhou, P; Frys, K; Ross, ME; Iadecola, C
Journal of Cerebral Blood Flow and Metabolism, 25(4): 493-501.
10.1038/sj.jcbfm.9600058
CrossRef
Journal of Neurochemistry
NO-induced neuroprotection in ischemic preconditioning stimulates mitochondrial Mn-SOD activity and expression via RAS/ERK1/2 pathway
Scorziello, A; Santillo, M; Adornetto, A; Dell'Aversano, C; Sirabella, R; Damiano, S; Canzoniero, LMT; Di Renzo, GF; Annunziato, L
Journal of Neurochemistry, 103(4): 1472-1480.
10.1111/j.1471-4159.2007.04845.x
CrossRef
Neural Regeneration Research
Effect of nicorandil on infarct volume and marker enzyme activity in mitochondria of rats with cerebral ischemia/reperfusion injury
Wang, P; Wang, SL; Li, SH; Chang, QX; Wang, SD
Neural Regeneration Research, 3(5): 501-504.

Stroke
Inducible Nitric Oxide Synthase Promoter Polymorphism Affords Protection Against Cognitive Dysfunction After Carotid Endarterectomy
Yocum, GT; Gaudet, JG; Lee, SS; Stern, Y; Teverbaugh, LA; Sciacca, RR; Emala, CW; Quest, DO; McCormick, PC; McKinsey, JF; Morrissey, NJ; Solomon, RA; Connolly, ES; Heyer, EJ
Stroke, 40(5): 1597-1603.
10.1161/STROKEAHA.108.541177
CrossRef
Neurological Research
Inhibition of caspase-9 activation and apoptosis is involved in ischemic preconditioning-induced neuroprotection in rat brain
Liu, YJ; Sercombe, R; Xie, DP; Liu, KJ; Chen, LB
Neurological Research, 29(8): 855-861.
10.1179/016164107X223575
CrossRef
Physiological Reviews
Molecular physiology of preconditioning-induced brain tolerance to ischemia
Obrenovitch, TP
Physiological Reviews, 88(1): 211-247.
10.1152/physrev.00039.2006
CrossRef
Expert Opinion on Therapeutic Targets
Ischaemic preconditioning: therapeutic implications for stroke?
Pong, K
Expert Opinion on Therapeutic Targets, 8(2): 125-139.

Anesthesiology
The Antibiotic Erythromycin Induces Tolerance against Transient Global Cerebral Ischemia in Rats (Pharmacologic Preconditioning)
Brambrink, AM; Koerner, IP; Diehl, K; Strobel, G; Noppens, R; Kempski, O
Anesthesiology, 104(6): 1208-1215.

PDF (960)
Back to Top | Article Outline

© 2002 American Society of Anesthesiologists, Inc.

Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.
Login

Article Tools

Images

Share